AssetMark’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.89K Sell
112
-863
-89% -$31.6K ﹤0.01% 2834
2026
Q2
$38.5K Sell
975
-423
-30% -$17K ﹤0.01% 1939
2026
Q1
$62.2K Buy
+1,398
New +$61.7K ﹤0.01% 1682

Other funds holding MDLN

AssetMark's MDLN Position: Q3 2026 in Review

AssetMark reduced its Medline Inc (MDLN) stake by 89% in Q3 2026, selling an estimated $31.6K and leaving 112 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2834.

AssetMark first reported a position in MDLN in Q1 2026 and has held it in 3 quarters since. The position peaked at $62.2K in Q1 2026. 315 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • AssetMark held 112 shares of Medline Inc worth $3.89K as of Q3 2026.
  • AssetMark sold 863 Medline Inc shares in Q3 2026, an estimated $31.6K.
  • Medline Inc made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2834 holding.
  • AssetMark first reported a position in Medline Inc in Q1 2026 and has held it in 3 quarters since.
  • AssetMark's Medline Inc position peaked at $62.2K in Q1 2026.
  • 315 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.